The report highlights the value-based healthcare system in South Korea, which has achieved a leading position in Asia. The report discusses the country's healthcare system, including its regulatory development, the health insurance review and assessment service (HIRA), and the national evidence-based healthcare collaborating agency (NECA). The report also addresses the issue of cost-effectiveness and funding decisions, as well as the controversy surrounding the level of funding. The report also discusses infectious diseases and chronic conditions, as well as the value of vaccines and drug costs and the resource dilemma.
